Skip to main content
. Author manuscript; available in PMC: 2024 Apr 9.
Published in final edited form as: Eur J Cancer. 2023 Mar 23;186:172–184. doi: 10.1016/j.ejca.2023.03.015

Fig. 2.

Fig. 2.

HRQoL Change From Baseline to Week 12 in the All-Comer Population at Week 12 (A, B) and Over Time (C-F). aPatient numbers for the sexual enjoyment functional scale and the sexual/vaginal problems symptom scales are LEN+PEMBRO: n = 65, TPC: n = 55. CI, confidence interval; EORTC QLQ-C30, European Organisation for Research and Treatment of Cancer Quality-of-Life Questionnaire; EORTC QLQ-EN24, EORTC QLQ-Endometrial, 24 questions; EQ-5D-5L, EuroQoL 5 dimensions, 5 levels; GHS/QoL, global health status/quality of life; HRQoL, health-related quality of life; LEN, lenvatinib; LS, least squares; PEMBRO, pembrolizumab; TPC, treatment of physician’s choice; VAS, visual analog scale.